Valuation Neurizon Therapeutics Limited

Equities

Market Closed - Australian S.E. Other stock markets 10:40:28 06/02/2026 am IST			5-day change	1st Jan Change
0.0930 ^AUD	-7.00%		+3.33%	+9.41%

20/01	Neurizon Therapeutics Obtains Global Trademark Protection in Major Markets	MT
20/01	Neurizon Therapeutics secures registered trademark protection for Neurizon® across all priority global markets	RE

Data adjusted to current consolidation scope

Fiscal Period: June	2020	2021	2022	2023	2024	2025
Capitalization ¹	46.81	28.82	22.18	26.06	86.78	78.77
Change	-	-38.43%	-23.03%	17.48%	232.99%	-9.23%
Enterprise Value (EV) ¹	45.4	27.08	21.15	24.39	76.05	74.59
Change	-	-40.36%	-21.89%	15.31%	211.83%	-1.92%
P/E ratio	-33.7x	-21.5x	-13x	-3.88x	-9.42x	-4.7x
PBR	5.49x	3.25x	2.83x	6.7x	8.48x	27.9x
PEG	-	2.71x	-0.5x	-0x	-1.36x	-0.1x
Capitalization / Revenue	11.4x	7.88x	4.92x	6.82x	103x	51.2x
EV / Revenue	11x	7.4x	4.69x	6.39x	90.4x	48.5x
EV / EBITDA	-41.5x	-24.4x	-14.6x	-7.91x	-13.1x	-4.4x
EV / EBIT	-36.4x	-21.3x	-13.1x	-7.5x	-13.1x	-4.4x
EV / FCF	-50.7x	-44x	-27.5x	-58x	-20.8x	-8.1x
FCF Yield	-1.97%	-2.27%	-3.63%	-1.72%	-4.8%	-12.4%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0046	-0.004235	-0.00539	-0.0194	-0.0207	-0.034
Distribution rate	-	-	-	-	-	-
Net sales ¹	4.12	3.657	4.51	3.819	0.8417	1.538
EBITDA ¹	-1.094	-1.109	-1.453	-3.081	-5.815	-16.94
EBIT ¹	-1.247	-1.273	-1.62	-3.254	-5.817	-16.94
Net income ¹	-1.362	-1.337	-1.708	-6.212	-7.673	-16.59
Net Debt ¹	-1.413	-1.746	-1.035	-1.673	-10.73	-4.181
Reference price ²	0.1550	0.0910	0.0700	0.0750	0.1950	0.1600
Nbr of stocks (in thousands)	3,02,021	3,16,730	3,16,912	3,47,475	4,45,024	4,92,306
Announcement Date	18/09/20	18/08/21	26/08/22	31/08/23	30/08/24	25/08/25

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NEURIZON THERAPEUTICS LIMITED	-	-	-	-	4.49Cr
ELI LILLY AND COMPANY	46.93x	15.27x	33.84x	0.55%	95TCr
JOHNSON & JOHNSON	23.2x	6.43x	17.86x	2.15%	58TCr
ABBVIE INC.	62.39x	7.4x	18.34x	2.93%	39TCr
ROCHE HOLDING AG	18.44x	4.63x	11.48x	2.82%	37TCr
MERCK & CO., INC.	15.75x	5.05x	11.01x	2.65%	30TCr
ASTRAZENECA PLC	30.26x	5.44x	16.24x	1.69%	30TCr
NOVARTIS AG	20.34x	5.75x	14.03x	2.97%	30TCr
AMGEN INC.	29.86x	6.92x	11.85x	2.49%	21TCr
NOVO NORDISK A/S	13.96x	4.82x	10.24x	3.65%	21TCr
Average	29.01x	6.86x	16.10x	2.43%	35.97TCr
Weighted average by Cap.	32.84x	8.36x	19.66x	2.06%